US Stock MarketDetailed Quotes

RAPT Therapeutics (RAPT)

Watchlist
  • 57.630
  • -0.010-0.02%
Close Jan 23 15:59 ET
  • 57.630
  • 0.0000.00%
Post 20:01 ET
1.67BMarket Cap-4.94P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RAPT Therapeutics (RAPT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-2.11%19.37M
-33.40%19.54M
-40.76%19.27M
7.11%136.1M
63.97%54.47M
-41.66%19.79M
3.41%29.33M
3.03%32.52M
45.51%127.06M
35.96%33.22M
Selling and administrative expenses
13.79%7.34M
7.55%7.2M
-6.64%7.22M
10.84%28.88M
24.11%8.01M
-6.51%6.45M
-0.48%6.69M
29.21%7.74M
28.75%26.06M
29.66%6.45M
-General and administrative expense
13.79%7.34M
7.55%7.2M
-6.64%7.22M
10.84%28.88M
24.11%8.01M
-6.51%6.45M
-0.48%6.69M
29.21%7.74M
28.75%26.06M
29.66%6.45M
Research and development costs
-9.79%12.03M
-45.49%12.34M
-51.41%12.04M
6.15%107.22M
73.58%46.46M
-50.63%13.34M
4.61%22.64M
-3.10%24.78M
50.56%101M
37.58%26.76M
Operating profit
2.11%-19.37M
33.40%-19.54M
40.76%-19.27M
-7.11%-136.1M
-63.97%-54.47M
41.66%-19.79M
-3.41%-29.33M
-3.03%-32.52M
-48.10%-127.06M
-35.96%-33.22M
Net non-operating interest income expense
Other net income (expense)
32.08%1.79M
13.50%1.89M
5.16%2.1M
-39.24%6.24M
-48.06%1.22M
-46.78%1.36M
-45.95%1.67M
-12.83%2M
424.48%10.26M
58.18%2.34M
Other non- operating income (expenses)
32.08%1.79M
13.50%1.89M
5.16%2.1M
-39.24%6.24M
-48.06%1.22M
-46.78%1.36M
-45.95%1.67M
-12.83%2M
424.48%10.26M
58.18%2.34M
Income before tax
4.62%-17.58M
36.22%-17.64M
43.76%-17.17M
-11.19%-129.87M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
Income tax
Net income
4.62%-17.58M
36.22%-17.64M
43.76%-17.17M
-11.19%-129.87M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
Net income continuous Operations
4.62%-17.58M
36.22%-17.64M
43.76%-17.17M
-11.19%-129.87M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
Minority interest income
Net income attributable to the parent company
4.62%-17.58M
36.22%-17.64M
43.76%-17.17M
-11.19%-129.87M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.62%-17.58M
36.22%-17.64M
43.76%-17.17M
-11.19%-129.87M
-72.46%-53.25M
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
Basic earnings per share
82.85%-0.65
88.58%-0.65
89.87%-0.64
-4.59%-25.52
-40.74%-9.12
42.23%-3.79
-7.77%-5.69
-3.95%-6.32
-18.22%-24.4
-26.56%-6.48
Diluted earnings per share
82.85%-0.65
88.58%-0.65
89.87%-0.64
-4.59%-25.52
-40.74%-9.12
42.23%-3.79
-7.77%-5.69
-3.95%-6.32
-18.22%-24.4
-26.56%-6.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -2.11%19.37M-33.40%19.54M-40.76%19.27M7.11%136.1M63.97%54.47M-41.66%19.79M3.41%29.33M3.03%32.52M45.51%127.06M35.96%33.22M
Selling and administrative expenses 13.79%7.34M7.55%7.2M-6.64%7.22M10.84%28.88M24.11%8.01M-6.51%6.45M-0.48%6.69M29.21%7.74M28.75%26.06M29.66%6.45M
-General and administrative expense 13.79%7.34M7.55%7.2M-6.64%7.22M10.84%28.88M24.11%8.01M-6.51%6.45M-0.48%6.69M29.21%7.74M28.75%26.06M29.66%6.45M
Research and development costs -9.79%12.03M-45.49%12.34M-51.41%12.04M6.15%107.22M73.58%46.46M-50.63%13.34M4.61%22.64M-3.10%24.78M50.56%101M37.58%26.76M
Operating profit 2.11%-19.37M33.40%-19.54M40.76%-19.27M-7.11%-136.1M-63.97%-54.47M41.66%-19.79M-3.41%-29.33M-3.03%-32.52M-48.10%-127.06M-35.96%-33.22M
Net non-operating interest income expense
Other net income (expense) 32.08%1.79M13.50%1.89M5.16%2.1M-39.24%6.24M-48.06%1.22M-46.78%1.36M-45.95%1.67M-12.83%2M424.48%10.26M58.18%2.34M
Other non- operating income (expenses) 32.08%1.79M13.50%1.89M5.16%2.1M-39.24%6.24M-48.06%1.22M-46.78%1.36M-45.95%1.67M-12.83%2M424.48%10.26M58.18%2.34M
Income before tax 4.62%-17.58M36.22%-17.64M43.76%-17.17M-11.19%-129.87M-72.46%-53.25M41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M
Income tax
Net income 4.62%-17.58M36.22%-17.64M43.76%-17.17M-11.19%-129.87M-72.46%-53.25M41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M
Net income continuous Operations 4.62%-17.58M36.22%-17.64M43.76%-17.17M-11.19%-129.87M-72.46%-53.25M41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M
Minority interest income
Net income attributable to the parent company 4.62%-17.58M36.22%-17.64M43.76%-17.17M-11.19%-129.87M-72.46%-53.25M41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.62%-17.58M36.22%-17.64M43.76%-17.17M-11.19%-129.87M-72.46%-53.25M41.25%-18.43M-9.43%-27.66M-4.27%-30.52M-39.31%-116.8M-34.53%-30.88M
Basic earnings per share 82.85%-0.6588.58%-0.6589.87%-0.64-4.59%-25.52-40.74%-9.1242.23%-3.79-7.77%-5.69-3.95%-6.32-18.22%-24.4-26.56%-6.48
Diluted earnings per share 82.85%-0.6588.58%-0.6589.87%-0.64-4.59%-25.52-40.74%-9.1242.23%-3.79-7.77%-5.69-3.95%-6.32-18.22%-24.4-26.56%-6.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.28%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.74%
4
Amazon
AMZN
+2.06%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.18%
Sample Name
Sample Code
 +8.06%
Sample Name
Sample Code
 +4.49%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.59%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -